Molecular Partners Ag (MOLN) Other Operating Expenses (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Other Operating Expenses for 5 consecutive years, with -$6.45 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 100.0% year-over-year to -$6.45 in Q2 2026; TTM through Jun 2026 was $25.7 million, a 79.89% decrease from a year earlier, with the FY2025 full-year figure at $91.7 million, up 66.05% from the prior year.
• Other Operating Expenses was -$6.45 for Q2 2026 at Molecular Partners Ag, down from $25.9 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $131.0 million in Q4 2024 and troughed at -$3.2 million in Q2 2025.
• A 3-year average of $21.9 million and a median of -$0.0 in 2024 frame the typical range for Other Operating Expenses.
• The widest YoY moves for Other Operating Expenses: up 200.0% in 2025, down 80.27% in 2025.
• Over 3 years, Other Operating Expenses stood at $131.0 million in 2024, then slumped by 80.27% to $25.9 million in 2025, then plunged by 100.0% to -$6.45 in 2026.
• The last three Other Operating Expenses figures came in at -$6.45 (Q2 2026), $25.9 million (Q4 2025), and -$143617.6 (Q3 2025), per Business Quant data.